BIND Therapeutics will be presenting a seminar as part of the DF/HCC Pipelines in Oncology series on Thursday, February 18 from 12:30-2:00pm at DFCI in Yawkey 306. The talk will be available by WebEx for those not able to attend in person; details to follow. BIND Therapeutics representatives will be meeting with investigators at MGH in the morning and at DFCI in the afternoon. If you are interested in a small group or 1:1 meeting, please contact Andrea Talis (MGH) or Deborah Goff (DFCI). Lunch will be provided at DFCI for the seminar.